Seidel P, Magnolo N
Dermatologie (Heidelb). 2024; 75(5):417-427.
PMID: 38451270
DOI: 10.1007/s00105-024-05310-1.
Rasmussen S, Kumar P, Trebbien R, Leutscher P, Rasmussen C
Eur J Rheumatol. 2023; 10(4):122-129.
PMID: 37873666
PMC: 10765197.
DOI: 10.5152/eurjrheum.2023.23053.
Elmer E, Nived P, Pettersson A, Skattum L, Hellmark T, Kapetanovic M
J Immunol Res. 2022; 2022:7561661.
PMID: 35935581
PMC: 9352482.
DOI: 10.1155/2022/7561661.
Abhishek A, Boyton R, McKnight A, Coates L, Bluett J, Barber V
BMJ Open. 2022; 12(5):e062599.
PMID: 35504634
PMC: 9066090.
DOI: 10.1136/bmjopen-2022-062599.
Dopfer-Jablonka A, Steffens S, Muller F, Mikuteit M, Niewolik J, Cossmann A
BMC Infect Dis. 2022; 22(1):403.
PMID: 35468758
PMC: 9035970.
DOI: 10.1186/s12879-022-07347-w.
Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19.
Yeaman M
Glomerular Dis. 2021; 1(4):277-293.
PMID: 34935004
PMC: 8678218.
DOI: 10.1159/000519182.
Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities.
Mohseni Afshar Z, Babazadeh A, Janbakhsh A, Mansouri F, Sio T, Sullman M
Rev Med Virol. 2021; 32(3):e2309.
PMID: 34677889
PMC: 8646697.
DOI: 10.1002/rmv.2309.
[The role of serum B cell activation factor in the diagnosis and phenotypes of chronic rhinosinusitis with nasal polyps].
Chen W, Wang L, Xie B, Xie S, Wang F
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021; 35(10):886-891.
PMID: 34628809
PMC: 10127701.
DOI: 10.13201/j.issn.2096-7993.2021.10.005.
Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases.
Friedman M, Curtis J, Winthrop K
Ann Rheum Dis. 2021; 80(10):1255-1265.
PMID: 34493491
PMC: 8494475.
DOI: 10.1136/annrheumdis-2021-221244.
CD47 Potentiates Inflammatory Response in Systemic Lupus Erythematosus.
Park J, Lee Y, Park J, Lee E, Song Y
Cells. 2021; 10(5).
PMID: 34068752
PMC: 8151692.
DOI: 10.3390/cells10051151.
Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients.
Nived P, Pettersson A, Jonsson G, Bengtsson A, Settergren B, Skattum L
Sci Rep. 2021; 11(1):9199.
PMID: 33911135
PMC: 8080705.
DOI: 10.1038/s41598-021-88491-2.
Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report.
Kralj M, Jakovac H
Clin Case Rep. 2021; 9(4):2269-2275.
PMID: 33821193
PMC: 8014728.
DOI: 10.1002/ccr3.4010.
A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review.
Soy M, Keser G, Atagunduz P, Yalcin Mutlu M, Gunduz A, Koybasi G
Clin Rheumatol. 2021; 40(9):3533-3545.
PMID: 33751280
PMC: 7982510.
DOI: 10.1007/s10067-021-05700-z.
COVID-19 vaccination in immunocompromised patients.
Sonani B, Aslam F, Goyal A, Patel J, Bansal P
Clin Rheumatol. 2021; 40(2):797-798.
PMID: 33426632
PMC: 7797352.
DOI: 10.1007/s10067-020-05547-w.
